Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 138 articles:
HTML format
Text format



Single Articles


    October 2019
  1. NOCON CC, Ajmani GS, Bhayani MK
    A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer.
    Cancer. 2019 Oct 3. doi: 10.1002/cncr.32342.
    PubMed     Text format     Abstract available


    September 2019
  2. LIN C, Cao SM, Chang ET, Liu Z, et al
    Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study.
    Cancer. 2019 Sep 22. doi: 10.1002/cncr.32458.
    PubMed     Text format     Abstract available


  3. ARGIRION I, Zarins KR, Ruterbusch JJ, Vatanasapt P, et al
    Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
    Cancer. 2019 Sep 16. doi: 10.1002/cncr.32517.
    PubMed     Text format     Abstract available


    August 2019
  4. AMENABAR JM, Torres-Pereira CC, Tang KD, Punyadeera C, et al
    Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    Cancer. 2019 Aug 7. doi: 10.1002/cncr.32435.
    PubMed     Text format     Abstract available


    July 2019
  5. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    PubMed     Text format     Abstract available


  6. SASAKI CT, Doukas SG, Costa J, Vageli DP, et al
    Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
    Cancer. 2019 Jul 16. doi: 10.1002/cncr.32369.
    PubMed     Text format     Abstract available


    June 2019
  7. HADDAD R, Concha-Benavente F, Blumenschein G Jr, Fayette J, et al
    Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
    Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190.
    PubMed     Text format     Abstract available


  8. KIM M, Kim BH, Kim JM, Kim EH, et al
    Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Cancer. 2019 Jun 19. doi: 10.1002/cncr.32166.
    PubMed     Text format     Abstract available


  9. PATEL SA, Qureshi MM, Dyer MA, Jalisi S, et al
    Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Cancer. 2019 Jun 17. doi: 10.1002/cncr.32292.
    PubMed     Text format     Abstract available


    May 2019
  10. PATIL VM, Noronha V, Joshi A, Agarwal J, et al
    A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
    Cancer. 2019 May 31. doi: 10.1002/cncr.32179.
    PubMed     Text format     Abstract available


  11. PARK A, Alabaster A, Shen H, Mell LK, et al
    Undertreatment of women with locoregionally advanced head and neck cancer.
    Cancer. 2019 May 15. doi: 10.1002/cncr.32187.
    PubMed     Text format     Abstract available


    April 2019
  12. TIAN S, Switchenko JM, Jhaveri J, Cassidy RJ, et al
    Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32115.
    PubMed     Text format     Abstract available


    February 2019
  13. NG SP, Pollard C 3rd, Berends J, Ayoub Z, et al
    Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.31983.
    PubMed     Text format     Abstract available


  14. LEE NCJ, Kelly JR, An Y, Park HS, et al
    Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
    Cancer. 2019 Feb 12. doi: 10.1002/cncr.32001.
    PubMed     Text format     Abstract available


    January 2019
  15. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.
    PubMed     Text format    


  16. WINDON MJ, D'Souza G, Faraji F, Troy T, et al
    Priorities, concerns, and regret among patients with head and neck cancer.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31920.
    PubMed     Text format     Abstract available


    December 2018
  17. JIANG C, Wang H, Xia C, Dong Q, et al
    A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31907.
    PubMed     Text format     Abstract available


  18. BADR H, Herbert K, Chhabria K, Sandulache VC, et al
    Self-management intervention for head and neck cancer couples: Results of a randomized pilot trial.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31906.
    PubMed     Text format     Abstract available


    November 2018
  19. CRACCHIOLO JR, Klassen AF, Young-Afat DA, Albornoz CR, et al
    Leveraging patient-reported outcomes data to inform oncology clinical decision making: Introducing the FACE-Q head and neck cancer module.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31900.
    PubMed     Text format     Abstract available


  20. EYTAN DF, Blackford AL, Eisele DW, Fakhry C, et al
    Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.
    Cancer. 2018 Nov 16. doi: 10.1002/cncr.31800.
    PubMed     Text format     Abstract available


  21. GREALLY M, Ilson DH
    Neoadjuvant therapy for esophageal cancer: Who, when, and what?
    Cancer. 2018;124:4276-4278.
    PubMed     Text format    


    October 2018
  22. HARADA K, Pool Pizzi M, Baba H, Shanbhag ND, et al
    Cancer stem cells in esophageal cancer and response to therapy.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31697.
    PubMed     Text format    


  23. GUO R, Tang LL, Mao YP, Du XJ, et al
    Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Cancer. 2018 Oct 23. doi: 10.1002/cncr.31741.
    PubMed     Text format     Abstract available


  24. THAM T
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31819.
    PubMed     Text format    


  25. CHAN JYW, Huang WB, Liu DL
    Reply to Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31815.
    PubMed     Text format    


  26. BAUML JM, Vinnakota R, Anna Park YH, Bates SE, et al
    Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of veterans health affairs data.
    Cancer. 2018 Oct 20. doi: 10.1002/cncr.31816.
    PubMed     Text format     Abstract available


  27. XIANG M, Holsinger FC, Colevas AD, Chen MM, et al
    Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
    Cancer. 2018 Oct 17. doi: 10.1002/cncr.31708.
    PubMed     Text format     Abstract available


  28. BAUMAN JE, Duvvuri U, Thomas S, Gooding WE, et al
    Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
    Cancer. 2018 Oct 6. doi: 10.1002/cncr.31651.
    PubMed     Text format     Abstract available


  29. SABA NF, Mendenhall WM, Hutcheson K, Suarez C, et al
    Salvage Surgery for Squamous Cell Carcinoma of the Head and Neck in the Era of Immunotherapy: Is It Time to Clarify Our Guidelines?
    Cancer. 2018 Oct 5. doi: 10.1002/cncr.31717.
    PubMed     Text format    


    August 2018
  30. SARAFIM-SILVA BAM, Duarte GD, Sundefeld MLMM, Biasoli ER, et al
    Childhood Trauma Is Predictive for Clinical Staging, Alcohol Consumption, and Emotional Symptoms in Patients With Head and Neck Cancer.
    Cancer. 2018 Aug 6. doi: 10.1002/cncr.31597.
    PubMed     Text format     Abstract available


    June 2018
  31. GRABOYES EM, Ellis MA, Li H, Kaczmar JM, et al
    Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival.
    Cancer. 2018 Jun 22. doi: 10.1002/cncr.31571.
    PubMed     Text format     Abstract available


    May 2018
  32. XIAO C, Beitler JJ, Higgins KA, Glazer T, et al
    Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31537.
    PubMed     Text format     Abstract available


  33. HO AS, Kim S, Tighiouart M, Mita A, et al
    Quantitative survival impact of composite treatment delays in head and neck cancer.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31533.
    PubMed     Text format     Abstract available


  34. WEISS JM, Grilley-Olson JE, Deal AM, Zevallos JP, et al
    Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
    Cancer. 2018 May 9. doi: 10.1002/cncr.31526.
    PubMed     Text format     Abstract available


    April 2018
  35. GUERRIERO MK, Redman MW, Baker KK, Martins RG, et al
    Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
    Cancer. 2018 Apr 18. doi: 10.1002/cncr.31407.
    PubMed     Text format     Abstract available


  36. WIRTH LJ, Tahara M, Robinson B, Francis S, et al
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
    Cancer. 2018 Apr 14. doi: 10.1002/cncr.31344.
    PubMed     Text format     Abstract available


  37. TOTA JE, Engels EA, Madeleine MM, Clarke CA, et al
    Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31359.
    PubMed     Text format     Abstract available


    March 2018
  38. HU J, Bao C, Gao J, Guan X, et al
    Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31318.
    PubMed     Text format     Abstract available


    February 2018
  39. ROCHE AM, Fedewa SA, Shi LL, Chen AY, et al
    Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Cancer. 2018 Feb 6. doi: 10.1002/cncr.31252.
    PubMed     Text format     Abstract available


    January 2018
  40. ZIMMARO LA, Sephton SE, Siwik CJ, Phillips KM, et al
    Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Cancer. 2018 Jan 22. doi: 10.1002/cncr.31109.
    PubMed     Text format     Abstract available


  41. NIKIFOROVA MN, Mercurio S, Wald AI, Barbi de Moura M, et al
    Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Cancer. 2018 Jan 18. doi: 10.1002/cncr.31245.
    PubMed     Text format     Abstract available


  42. WEEKS KS, Kahl AR, Lynch CF, Charlton ME, et al
    Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31229.
    PubMed     Text format     Abstract available


  43. XIAO R, Ward MC, Yang K, Adelstein DJ, et al
    Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31213.
    PubMed     Text format     Abstract available


  44. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available


  45. SAWABE M, Ito H, Takahara T, Oze I, et al
    Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
    Cancer. 2018;124:118-124.
    PubMed     Text format     Abstract available


  46. NEUWIRTH MG, Bierema C, Sinnamon AJ, Fraker DL, et al
    Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?
    Cancer. 2018;124:125-135.
    PubMed     Text format     Abstract available


    December 2017
  47. ROTH MY, Witt RL, Steward DL
    Molecular testing for thyroid nodules: Review and current state.
    Cancer. 2017 Dec 26. doi: 10.1002/cncr.30708.
    PubMed     Text format     Abstract available


  48. DAHLSTROM KR, Anderson KS, Field MS, Chowell D, et al
    Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Cancer. 2017;123:4886-4894.
    PubMed     Text format     Abstract available


  49. CHIN RI, Rao YJ, Hwang MY, Spencer CR, et al
    Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil.
    Cancer. 2017;123:4594-4607.
    PubMed     Text format     Abstract available


    November 2017
  50. ALI SM, Ross JS, Wang K
    Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31132.
    PubMed     Text format    


  51. LUI VWY, To KF, Lo KW
    Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.
    Cancer. 2017 Nov 22. doi: 10.1002/cncr.31131.
    PubMed     Text format    


  52. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Text format     Abstract available


  53. PRINTZ C
    First person: Maura L. Gillison, MD, PhD: The researcher who found the link between the human papillomavirus and head and neck cancers continues to lead new discoveries in the field.
    Cancer. 2017;123:4307.
    PubMed     Text format    


  54. LANG KUHS KA, Kreimer AR, Trivedi S, Holzinger D, et al
    Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer. 2017;123:4382-4390.
    PubMed     Text format     Abstract available


  55. GUPTA A, Sonis ST, Schneider EB, Villa A, et al
    Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31095.
    PubMed     Text format     Abstract available


  56. HOBAN CW, Beesley LJ, Bellile EL, Sun Y, et al
    Individualized outcome prognostication for patients with laryngeal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31087.
    PubMed     Text format     Abstract available


  57. CHANDLER JB, Colunga M, Prasad ML, Callender GG, et al
    Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Cancer. 2017;125:865-875.
    PubMed     Text format     Abstract available


    October 2017
  58. HUANG WB, Chan JYW, Liu DL
    Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.
    Cancer. 2017 Oct 26. doi: 10.1002/cncr.31031.
    PubMed     Text format     Abstract available


  59. BURTNESS B
    The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31059.
    PubMed     Text format    


  60. GLEBER-NETTO FO, Zhao M, Trivedi S, Wang J, et al
    Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31063.
    PubMed     Text format     Abstract available


  61. AMIT M, Tam S, Abdelmeguid AS, Roberts DB, et al
    Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31083.
    PubMed     Text format     Abstract available


  62. SHEN CJ, Hu C, Ladra MM, Narang AK, et al
    Socioeconomic factors affect the selection of proton radiation therapy for children.
    Cancer. 2017;123:4048-4056.
    PubMed     Text format     Abstract available


  63. WANG Z, Cheng Y, Abraham JM, Yan R, et al
    RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1-MELK, arising from a complex chromosomal rearrangement.
    Cancer. 2017;123:3916-3924.
    PubMed     Text format     Abstract available


  64. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available


  65. CAPARROTTI F, Huang SH, Lu L, Bratman SV, et al
    Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Cancer. 2017;123:3691-3700.
    PubMed     Text format     Abstract available


  66. GRIFFITH CC, Schmitt AC, Pantanowitz L, Monaco SE, et al
    A pattern-based risk-stratification scheme for salivary gland cytology: A multi-institutional, interobserver variability study to determine applicability.
    Cancer. 2017;125:776-785.
    PubMed     Text format     Abstract available


  67. ROHILLA M, Singh P, Rajwanshi A, Gupta N, et al
    Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification.
    Cancer. 2017;125:767-775.
    PubMed     Text format     Abstract available


  68. ROSSI ED, Faquin WC, Baloch Z, Barkan GA, et al
    The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey.
    Cancer. 2017;125:757-766.
    PubMed     Text format     Abstract available


    September 2017
  69. SACCO AG, Cohen EE
    Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30970.
    PubMed     Text format    



  70. Researchers delve into thyroid cancer disparities in race and age: Incidence of the disease continues to grow, but at a slower rate in some groups.
    Cancer. 2017;123:3431-3432.
    PubMed     Text format    


  71. MITO JK, Alexander EK, Angell TE, Barletta JA, et al
    A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Cancer. 2017 Sep 13. doi: 10.1002/cncy.21907.
    PubMed     Text format     Abstract available


  72. BLUM MURPHY M, Xiao L, Patel VR, Maru DM, et al
    Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30953.
    PubMed     Text format     Abstract available


  73. SABA NF
    Refining the predictors of outcome in patients with resectable esophageal cancer.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30952.
    PubMed     Text format    


  74. NGUYEN MT, Hu J, Hastings KG, Daza EJ, et al
    Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using National Mortality Records from 2003 through 2012.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30958.
    PubMed     Text format     Abstract available


  75. RODEN DF, Schreiber D, Givi B
    Triple-modality treatment in patients with advanced stage tonsil cancer.
    Cancer. 2017;123:3269-3276.
    PubMed     Text format     Abstract available


    August 2017
  76. GRABOYES EM, Garrett-Mayer E, Ellis MA, Sharma AK, et al
    Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30939.
    PubMed     Text format     Abstract available


  77. ZUMSTEG ZS, Luu M, Yoshida EJ, Kim S, et al
    Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30933.
    PubMed     Text format     Abstract available


  78. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30943.
    PubMed     Text format     Abstract available


  79. ALBERGOTTI WG, Jordan J, Anthony K, Abberbock S, et al
    A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Cancer. 2017;123:3132-3140.
    PubMed     Text format     Abstract available


  80. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available


  81. ROBIN TP, Jones BL, Gordon OM, Phan A, et al
    A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Cancer. 2017;123:3040-3049.
    PubMed     Text format     Abstract available


  82. BHATIA AK, Lee JW, Pinto HA, Jacobs CD, et al
    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Cancer. 2017 Aug 7. doi: 10.1002/cncr.30920.
    PubMed     Text format     Abstract available


  83. ROOPER LM, Onenerk M, Siddiqui MT, Faquin WC, et al
    Nodular oncocytic hyperplasia: Can cytomorphology allow for the preoperative diagnosis of a nonneoplastic salivary disease?
    Cancer. 2017;125:627-634.
    PubMed     Text format     Abstract available


    July 2017
  84. SANDMAEL JA, Bye A, Solheim TS, Stene GB, et al
    Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial.
    Cancer. 2017 Jul 31. doi: 10.1002/cncr.30901.
    PubMed     Text format     Abstract available


  85. RENSHAW AA, Gould EW
    Adequate sampling of multiple thyroid nodules by fine-needle aspiration.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21904.
    PubMed     Text format     Abstract available


  86. CRAMER JD, Speedy SE, Ferris RL, Rademaker AW, et al
    National evaluation of multidisciplinary quality metrics for head and neck cancer.
    Cancer. 2017 Jul 20. doi: 10.1002/cncr.30902.
    PubMed     Text format     Abstract available


  87. AN Y, Park HS, Kelly JR, Stahl JM, et al
    The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:2762-2772.
    PubMed     Text format     Abstract available


  88. CHANDRASEKHARAPPA SC, Chinn SB, Donovan FX, Chowdhury NI, et al
    Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30802.
    PubMed     Text format     Abstract available


  89. OHORI NP, Wolfe J, Carty SE, Yip L, et al
    The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.
    Cancer. 2017 Jul 5. doi: 10.1002/cncy.21892.
    PubMed     Text format     Abstract available


  90. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Text format     Abstract available


  91. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available


    June 2017
  92. LEE AWM, Tung SY, Ng WT, Lee V, et al
    A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30850.
    PubMed     Text format     Abstract available


  93. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Text format     Abstract available


  94. DAVID JM, Ho AS, Luu M, Yoshida EJ, et al
    Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30843.
    PubMed     Text format     Abstract available


  95. WANG FH, Wang Y, Sun GP, Chen JH, et al
    Efficacy and safety of recombinant human lymphotoxin-alpha derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30845.
    PubMed     Text format     Abstract available


  96. CHO M, Oweity T, Brandler TC, Fried K, et al
    Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
    Cancer. 2017 Jun 16. doi: 10.1002/cncy.21888.
    PubMed     Text format     Abstract available


  97. WALTERHOUSE DO, Pappo AS, Meza JL, Breneman JC, et al
    Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Cancer. 2017;123:2368-2375.
    PubMed     Text format     Abstract available


  98. KONG L, Zhang Y, Hu C, Guo Y, et al
    Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Cancer. 2017;123:2258-2267.
    PubMed     Text format     Abstract available


  99. LIN WC, Ding YF, Hsu HL, Chang JH, et al
    Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
    Cancer. 2017 Jun 13. doi: 10.1002/cncr.30823.
    PubMed     Text format     Abstract available


  100. ALI SM, Yao M, Yao J, Wang J, et al
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Cancer. 2017 Jun 5. doi: 10.1002/cncr.30781.
    PubMed     Text format     Abstract available


  101. ROSSI ED, Martini M, Cenci T, Capodimonti S, et al
    The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.
    Cancer. 2017 Jun 5. doi: 10.1002/cncy.21884.
    PubMed     Text format     Abstract available


  102. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Text format     Abstract available


  103. KIM Y, Lee SJ, Lee JY, Lee SH, et al
    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
    Cancer. 2017;123:1958-1964.
    PubMed     Text format     Abstract available


  104. ONENERK AM, Pusztaszeri MP, Canberk S, Faquin WC, et al
    Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Cancer. 2017;125.
    PubMed     Text format     Abstract available


    May 2017
  105. HANG JF, Westra WH, Cooper DS, Ali SZ, et al
    The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Cancer. 2017 May 24. doi: 10.1002/cncy.21879.
    PubMed     Text format     Abstract available


  106. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    PubMed     Text format     Abstract available


  107. MALM IJ, Fan CJ, Yin LX, Li DX, et al
    Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:1768-1777.
    PubMed     Text format     Abstract available


  108. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Text format     Abstract available


  109. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Text format     Abstract available


  110. PAI SI, Faquin WC
    Programmed cell death ligand 1 as a biomarker in head and neck cancer.
    Cancer. 2017 May 4. doi: 10.1002/cncy.21872.
    PubMed     Text format    


  111. NAIK KB, Liu Y, Goodman M, Gillespie TW, et al
    Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30763.
    PubMed     Text format     Abstract available


  112. FAKHRY C, Westra WH, Wang SJ, van Zante A, et al
    The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Cancer. 2017;123:1566-1575.
    PubMed     Text format     Abstract available


  113. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Text format     Abstract available


    April 2017
  114. SHAH BR, Griffiths R, Hall SF
    Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30746.
    PubMed     Text format     Abstract available


  115. ZUMSTEG ZS, Lok BH, Ho AS, Drill E, et al
    The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Cancer. 2017;123:1345-1353.
    PubMed     Text format     Abstract available


  116. VIVERO M, Renshaw AA, Krane JF
    Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
    Cancer. 2017 Apr 7. doi: 10.1002/cncy.21858.
    PubMed     Text format     Abstract available


  117. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  118. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


  119. D'SOUZA G, Robbins HA
    Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.
    Cancer. 2017;123:1092-1094.
    PubMed     Text format    


    March 2017
  120. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Text format     Abstract available


  121. SINHA P, Haughey BH, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharyngeal carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:887-888.
    PubMed     Text format    


    February 2017
  122. DRAHOS J, Ricker W, Pfeiffer RM, Cook MB, et al
    Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
    Cancer. 2017;123:657-665.
    PubMed     Text format     Abstract available


  123. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Text format     Abstract available


  124. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available


    January 2017
  125. HUTCHESON KA, Barrow MP, Barringer DA, Knott JK, et al
    Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation.
    Cancer. 2017;123:62-70.
    PubMed     Text format     Abstract available


  126. SHER DJ, Rusthoven CG, Khan SA, Fidler MJ, et al
    National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Cancer. 2017;123:273-282.
    PubMed     Text format     Abstract available


  127. COOPER JS, Fortpied C, Gregoire V, Le QT, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
    Cancer. 2017;123:12-16.
    PubMed     Text format    


  128. COLLINS GS, Le Manach Y
    Nomograms need to be presented in full.
    Cancer. 2017;123:177-178.
    PubMed     Text format    


  129. CHOI HC, Xu W, Lee AW
    Reply to Nomograms need to be presented in full.
    Cancer. 2017;123:178-179.
    PubMed     Text format    


    December 2016
  130. BISHOP JA, French CA, Ali SZ
    Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients.
    Cancer. 2016;124:901-908.
    PubMed     Text format     Abstract available


    November 2016
  131. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Text format     Abstract available


  132. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Text format     Abstract available


    October 2016
  133. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Text format     Abstract available


    September 2016
  134. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Text format     Abstract available


    August 2016
  135. SHERMAN SI, Clary DO, Elisei R, Schlumberger MJ, et al
    Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30252.
    PubMed     Text format     Abstract available


  136. LUBITZ CC, Sosa JA
    The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
    Cancer. 2016 Aug 12. doi: 10.1002/cncr.30201.
    PubMed     Text format     Abstract available


    July 2016
  137. KU GY, Kriplani A, Janjigian YY, Kelsen DP, et al
    Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.
    Cancer. 2016;122:2083-90.
    PubMed     Text format     Abstract available


  138. HORNE ZD, Glaser SM, Vargo JA, Ferris RL, et al
    Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Cancer. 2016;122:2021-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: